• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assay of heparin in plasma using a chromogenic substrate for activated factor X.

作者信息

Teien A N, Lie M, Abildgaard U

出版信息

Thromb Res. 1976 Mar;8(3):413-6. doi: 10.1016/0049-3848(76)90034-7.

DOI:10.1016/0049-3848(76)90034-7
PMID:1265712
Abstract
摘要

相似文献

1
Assay of heparin in plasma using a chromogenic substrate for activated factor X.使用针对活化因子X的显色底物测定血浆中的肝素。
Thromb Res. 1976 Mar;8(3):413-6. doi: 10.1016/0049-3848(76)90034-7.
2
[The determination of heparin].
Ann Biol Clin (Paris). 1982;40(6):645-50.
3
Thrombin generation and neutralization test (TGNT) - a simple, practical, and sensitive assay for plasma heparin quantitation.凝血酶生成与中和试验（TGNT）——一种用于血浆肝素定量的简单、实用且灵敏的检测方法。
Thromb Haemost. 1978 Jun 30;39(3):631-9.
4
Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats.活化蛋白C或抗凝血酶对凝血和炎症的抑制作用可减轻大鼠肠道缺血/再灌注损伤。
Crit Care Med. 2004 Jun;32(6):1375-83. doi: 10.1097/01.ccm.0000128567.57761.e9.
5
The antiheparin effect of alpha 1-acid glycoprotein, evaluated by the activated partial thromboplastin time and by a factor Xa assay for heparin.通过活化部分凝血活酶时间和肝素的Xa因子测定法评估α1-酸性糖蛋白的抗肝素作用。
Haemostasis. 1980;9(5):303-9. doi: 10.1159/000214369.
6
Identification of two distinct heparin cofactors in human plasma. II. Inhibition of thrombin and activated factor X.人血浆中两种不同肝素辅因子的鉴定。II. 凝血酶和活化因子X的抑制作用
Thromb Res. 1974 Mar;4(3):463-77. doi: 10.1016/0049-3848(74)90081-4.
7
Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.体外循环期间高剂量肝素化监测——凝血酶原酶诱导凝血时间（PiCT）与两种发色底物法抗Xa因子活性测定的比较
Thromb Haemost. 2008 Feb;99(2):427-34. doi: 10.1160/TH07-04-0307.
8
Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.体外循环中肝素的剂量与监测：采用亚临床血浆凝血检测技术的比较
J Thorac Cardiovasc Surg. 1990 Mar;99(3):518-27.
9
[Heparin-induced impairment of thrombin interaction with fibrinogen and receptors of the anti-coagulation system].[肝素诱导的凝血酶与纤维蛋白原及抗凝系统受体相互作用的损害]
Vopr Med Khim. 1986 May-Jun;32(3):132-6.
10
Determination of factor X and heparin with chromogenic substrate.用显色底物法测定因子X和肝素。
Acta Chir Scand Suppl. 1982;509:109-13.

引用本文的文献

1
Optimization of Heparin Monitoring with Anti-FXa Assays and the Impact of Dextran Sulfate for Measuring All Drug Activity.使用抗Xa因子测定法优化肝素监测以及硫酸葡聚糖对测量所有药物活性的影响。
Biomedicines. 2021 Jun 21;9(6):700. doi: 10.3390/biomedicines9060700.
2
A less-intensive anticoagulation protocol of therapeutic unfractionated heparin administration for pregnant patients.针对妊娠患者的低强度抗凝方案：给予治疗剂量的未分级肝素。
Int J Hematol. 2019 Nov;110(5):550-558. doi: 10.1007/s12185-019-02712-z. Epub 2019 Jul 25.
3
Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions.
不同实验室检测方法在临床实践中监测未分级肝素的准确性、可重复性和成本：一项前瞻性评估研究及瑞士医疗机构调查。
BMJ Open. 2018 Jun 9;8(6):e022943. doi: 10.1136/bmjopen-2018-022943.
4
Clinical Scenarios for Discordant Anti-Xa.抗Xa检测结果不一致的临床案例
Adv Hematol. 2016;2016:4054806. doi: 10.1155/2016/4054806. Epub 2016 May 12.
5
Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin.在治疗剂量肝素作用下，凝血因子VIII水平对活化部分凝血活酶时间（APTT）及抗Xa活性的影响。
Int J Hematol. 2015 Feb;101(2):119-25. doi: 10.1007/s12185-014-1702-z. Epub 2014 Nov 23.
6
Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade.能够恢复凝血级联反应稳态调节的自滴定抗凝纳米复合物。
ACS Nano. 2014 Sep 23;8(9):8776-85. doi: 10.1021/nn501129q. Epub 2014 Aug 19.
7
Inhibition of intrinsic thrombin generation.抑制内源性凝血酶生成。
Drug Target Insights. 2006;1:5-10. Epub 2006 Oct 23.
8
Quantitative Determination of High Charge Density Polyanion Contaminants in Biomedical Heparin Preparations Using Potentiometric Polyanion Sensors.使用电位型聚阴离子传感器定量测定生物医学肝素制剂中的高电荷密度聚阴离子污染物
Electroanalysis. 2010 Jan;22(1):26-30. doi: 10.1002/elan.200900434.
9
Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.以甘草次酸作为渗透促进剂配制的低分子量肝素的口服生物利用度评价
Drug Dev Res. 2006 Feb;67(2):166-174. doi: 10.1002/ddr.20087.
10
Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.在体外循环手术期间使用一步即时全血抗Xa因子凝血测定法（HepTest - POC - Hi）进行肝素监测。
J Extra Corpor Technol. 2007 Jun;39(2):81-6.